Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
about
Crystal structure of the heterodimeric complex of LXR and RXR ligand-binding domains in a fully agonistic conformationExtracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencingSelective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins.The color appearance of stimuli detected via short-wavelength-sensitive cones: comparisons with visual adaptation and visual field data for peri- or post-menopausal women under 70 years of age.Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice.Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.ESTROGEN REPLACEMENT THERAPY FOR STROKE.Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.A novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha).Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current.Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.Short wavelength automated perimetry and tamoxifen use.Antifibrotic effect of tamoxifen in a model of progressive renal disease.Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trialQuinol-based cyclic antioxidant mechanism in estrogen neuroprotectionChemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.Arzoxifene: the development and clinical outcome of an ideal SERM.Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer.Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia.Prenylated isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs).Characterization of ligand type of estrogen receptor by MD simulation and mm-PBSA free energy analysis.Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2.A novel ERα-mediated reporter gene assay for screening estrogenic/antiestrogenic chemicals based on LLC-MK2 cells.Towards an integrated in vitro strategy for estrogenicity testing.SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo.Peptide binding identifies an ERalpha conformation that generates selective activity in multiple in vitro assays.Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized ratsNon-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression.Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats.Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.Enhanced operant extinction and prefrontal excitability in a mouse model of Angelman syndrome.Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
P2860
Q27642012-F0AD5ABE-B98E-4AB9-9664-1CC2E28511B8Q28580406-562AD7F8-6F92-47E6-8169-6718B5393907Q28677420-CB164B7F-EE57-4E68-A258-99BF5936F1E8Q30450954-4D5C2F5F-44CB-456F-A4A6-B525EA390922Q31149665-C4069A94-A148-4547-9151-4F97B7A66E18Q33369585-802BCEA7-C7FC-4AE3-AB93-E413599ECE62Q33756323-6787BFE0-1F34-4DCE-808E-1BD8BF2707A2Q33840436-30E1918B-AD80-4CA5-A244-B3BCC727F402Q33992426-3E546525-1302-42A9-B197-9A89A82B982EQ34052372-37F0A1E1-FB28-4382-8021-5627BCDECCB3Q34193867-CE63BE0A-FE70-45B9-99FC-6C729819A3D6Q34322874-CE45A5D6-92D9-477E-A644-6DD41137719FQ35047098-5AFCA660-101F-478E-8250-A071FDC54A6EQ35221939-703E074E-ECB5-4C8B-831E-4B08C95FB7C0Q35591670-9F634A31-1D20-4F04-A5B5-FCFCAF96DFFFQ35720759-AEDEF170-980E-4459-AFCD-4D7E78EF3010Q35749504-5FDE6041-9374-4619-90EF-65A479D14135Q35829785-C68EEF2B-D7B9-42F6-9FBB-3F7384DF9B60Q36161592-8DEF08D0-F730-4610-BDE5-F96162B00B36Q36306224-C564F14A-1D91-493D-BAFE-F9A56C4D18EFQ36407322-B8520F1E-FA08-40AA-B355-B1A8EE5E99C7Q36848788-77E638B3-044B-4CE2-815E-1704C13739CFQ36943022-18DE42F1-92BA-4E00-861F-6FA9D031E676Q37349868-3F0615D2-3637-404C-B7FD-92639E001D88Q38017574-FDEC6575-7100-4C30-9234-0D624A3BA4C6Q38561796-875B9659-0F46-4ABD-BC75-9143C0D47499Q38861431-021A33F1-B237-48D8-A735-D16205CAF8F5Q38973326-95B987B5-9A33-4591-B6CF-7DC40C567251Q39082204-92696A1B-D343-4054-924B-3CB39A672FFFQ39628302-E27C9A2D-8522-4A55-9AA0-3A5EFA2FE808Q40384503-835E4F9C-4628-47F4-8402-7C2384B2463EQ41700375-56439E38-0B3F-4FBD-AFBD-25136D193A40Q42284550-FCD55E93-2E55-4324-B0C5-15BA54A1F2CFQ44720800-A9558571-A1AD-4319-ADB8-B511A32E174AQ46815750-BDEFF473-75E2-461C-8893-5F19BFB8693AQ47607904-BA2FF36F-4A54-4AC3-A933-A553CDE59BC7Q47717137-D66A7534-B822-4357-B85C-5F49849DD230Q50066459-DC0D6DC6-9E70-4AEE-A75C-884A63D46B75Q53270018-812FC6BA-CD80-4133-8B77-E679BFA15526
P2860
Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular perspectives on sele ...... gonist and antagonist actions.
@ast
Molecular perspectives on sele ...... gonist and antagonist actions.
@en
Molecular perspectives on selective estrogen receptor modulators
@nl
type
label
Molecular perspectives on sele ...... gonist and antagonist actions.
@ast
Molecular perspectives on sele ...... gonist and antagonist actions.
@en
Molecular perspectives on selective estrogen receptor modulators
@nl
prefLabel
Molecular perspectives on sele ...... gonist and antagonist actions.
@ast
Molecular perspectives on sele ...... gonist and antagonist actions.
@en
Molecular perspectives on selective estrogen receptor modulators
@nl
P1433
P1476
Molecular perspectives on sele ...... gonist and antagonist actions.
@en
P2093
Carolyn L Smith
David M Lonard
P356
10.1016/S0039-128X(01)00133-7
P577
2002-01-01T00:00:00Z